Literature DB >> 2970476

Systemic retinoid therapy for psoriasis.

N J Lowe1, V Lazarus, L Matt.   

Abstract

Retinoids are potent therapuetic agents that have been found to be effective in a variety of skin diseases. They are of benefit in various forms of severe psoriasis. With severe plaque psoriasis, they are used most effectively in combination with other forms of therapy, such as phototherapy. With generalized pustular psoriasis, they are effective monotherapy and are frequently helpful for the control of exfoliative psoriasis. A variety of new retinoid analogs have been studied in clinical investigations. This article discusses important aspects of the use of etretinate, isotretinoin, acitretin, and arotinoid ethyl ester in the treatment of severe forms of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970476     DOI: 10.1016/s0190-9622(88)70163-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?

Authors:  B Lindelöf
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 3.  Psoriasis treatment: current and emerging directed therapies.

Authors:  L S Winterfield; A Menter; K Gordon; A Gottlieb
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

4.  Polyprenoic acid, E-5166, is effective in inhibiting the proliferation of keratinocytes in vitro.

Authors:  M Koji; T Kanzaki; A Takashima
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.